Mylan Inc. (>> Mylan Inc) and Pfizer Inc. (>>
Pfizer Inc.) will pay Massachusetts a total of $625,000 to settle a case over
television ads for a device used to treat allergic reactions, the office of
Massachusetts Attorney General Martha Coakley said Thursday.
The device, EpiPen, allows for self-injection of
FDA-approved steroid epinephrine for emergency treatment of allergic reactions.
Pfizer makes the devices, and Mylan markets them under a licensing deal. The
television ad in question, which aired in April 2012, along with a similar
print ad, misled consumers into thinking that only EpiPen can prevent allergic
reactions, the Massachusetts office said.
The companies are required to submit new ad campaigns for
EpiPen and EpiPen Jr. to the U.S. Food and Drug Administration for pre-review. Mylan
also settled with Oregon over the ads, agreeing to pay $250,000, that state's
Department of Justice said. Pfizer in December agreed to pay Oregon $1 million
over the campaign. Read more
No comments:
Post a Comment